Androgen Deprivation Therapy Treatment Update will be held at the at the Lucy Curci Cancer Center on Monday, September 24 2012 from 05:30PM to 07:00PM.
Because testosterone and dihydrotestosterone are thought to stimulate prostate cancer cells to grow, the goal of ADT for prostate cancer patients is to reduce the level of these male hormones or prevent them from reaching prostate cancer cells.
Please join Dr. Leifer to discuss the how, what, where and whys of ADT therapy. Complimentary light dinner included.
Speakers for this event include; Gary Leifer, MD. Gary Leifer, MD is Board Certified in Urology.